CTT Pharma Files a Patent Continuation with the U.S. Patent Office
CTT Pharma Corporate Updates
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology
CTT Pharma Receives SEC Approval
CTT Pharma Signs LOI with European Company
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
CTT Pharma's CEO will issue a Letter to Shareholders
CTT Pharma Signs Contract for $3 Million Equity Line of Credit